Redsense Medical AB (publ)
Redsense Medical AB (publ) develops, markets, and sells monitoring systems for medical treatments primarily in Europe and the United States. The company offers Redsense System, a medical technology product that is used for monitoring and alarming in the event of blood leakage in connection with a hemodialysis treatment. It also provides Redsense Clamp, which clamps the bloodline to stop blood flo… Read more
Redsense Medical AB (publ) (RDSNF) - Total Liabilities
Latest total liabilities as of June 2024: $4.23 Million USD
Based on the latest financial reports, Redsense Medical AB (publ) (RDSNF) has total liabilities worth $4.23 Million USD as of June 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Redsense Medical AB (publ) - Total Liabilities Trend (2019–2023)
This chart illustrates how Redsense Medical AB (publ)'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Redsense Medical AB (publ) Competitors by Total Liabilities
The table below lists competitors of Redsense Medical AB (publ) ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
NINtec Systems Limited
NSE:NINSYS
|
India | ₹648.06 Million |
|
Comet Industries Ltd
V:CMU
|
Canada | CA$139.00K |
|
Nexus Uranium Corp.
F:JA7
|
Germany | €60.30K |
|
Wellgistics Health, Inc. Common Stock
NASDAQ:WGRX
|
USA | $46.00 Million |
|
Bulletin Resources Ltd
AU:BNR
|
Australia | AU$1.23 Million |
|
Pan Asia Footwear Public Company Limited
BK:PAF
|
Thailand | ฿469.08 Million |
|
ViroGates A/S
CO:VIRO
|
Denmark | Dkr11.38 Million |
|
Republic Airways Holdings Inc
NASDAQ:RJET
|
USA | $211.57 Million |
Liability Composition Analysis (2019–2023)
This chart breaks down Redsense Medical AB (publ)'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.86 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.14 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.12 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Redsense Medical AB (publ)'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Redsense Medical AB (publ) (2019–2023)
The table below shows the annual total liabilities of Redsense Medical AB (publ) from 2019 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | $3.41 Million | -4.80% |
| 2022-12-31 | $3.58 Million | -37.78% |
| 2021-12-31 | $5.76 Million | +4.58% |
| 2020-12-31 | $5.51 Million | +36.15% |
| 2019-12-31 | $4.04 Million | -- |